FDA Considers Approval for Moderna's mRNA Flu Vaccine

Why it matters locally: While not directly affecting specific Kansas industries more than others, the approval of Moderna's mRNA flu vaccine could influence public health strategies and vaccine distribution channels across the state, including for organizations like the Kansas Department of Health and Environment.

---

The Food and Drug Administration (FDA) is preparing to issue a ruling on Moderna's messenger RNA (mRNA) flu vaccine. This vaccine, if approved, would become the first mRNA-based influenza shot available commercially. Observers expect the FDA's decision to affect the biotechnology industry broadly.